Impaired Mechanobiological Healing Following Surgical Tissue Injury: Mechanisms, Clinical Implications, and Emerging Strategies

Abstract

Impaired mechanobiological healing following surgical tissue injury represents a significant challenge in modern medicine, affecting patient outcomes and increasing healthcare burdens. This review synthesizes current evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic methods, therapeutic options, emerging interventions, and guideline recommendations. Emphasis is placed on the mechanobiological principles underlying tissue repair, the impact of disrupted mechanical signaling, and the translation of research findings into clinical practice.

Introduction

Surgical interventions, while often life-saving or restorative, inherently disrupt tissue integrity and initiate complex healing responses. Optimal postoperative recovery relies on the integration of biological and mechanical cues. When mechanobiological healing is impaired, patients face increased risks of complications such as chronic wounds, dehiscence, fibrosis, and functional deficits. Understanding the cellular and molecular mechanisms driving normal and aberrant healing is crucial for developing targeted therapies and improving prognoses.

Epidemiology / Disease Burden

Impaired postoperative healing is a prevalent issue, with studies reporting complications in 10-30% of major surgeries, depending on tissue type and patient comorbidities. For example, incisional hernias develop in up to 20% of abdominal surgeries, and non-healing surgical wounds contribute significantly to morbidity, readmissions, and healthcare costs. The burden is particularly high in orthopedic, cardiovascular, and oncologic surgeries, where tissue function is paramount. The aging population and rising prevalence of comorbid conditions further magnify the impact on global health systems.

Pathophysiology

Mechanobiological healing involves the orchestration of cellular responses to both biochemical signals and mechanical forces. Following surgical injury, hemostasis and inflammation are followed by proliferation and remodeling, during which mechanical loading influences cell differentiation, matrix deposition, and tissue strength. Impairment arises when mechanical cues are disrupted either by excessive or insufficient loading, altered extracellular matrix (ECM) composition, or dysregulated mechanotransduction pathways (e.g., YAP/TAZ, integrins, and stretch-activated ion channels). Hypoxia, persistent inflammation, or uncoordinated fibroblast activity can further derail the healing cascade, resulting in weak scar formation, fibrosis, or chronic wounds.

Risk Factors

Patient-related risk factors include advanced age, diabetes mellitus, obesity, malnutrition, smoking, immunosuppression, and genetic predispositions affecting collagen or ECM proteins. Surgical factors encompass the extent of tissue disruption, surgical technique, tension at closure, and adequacy of vascular supply. Systemic conditions such as chronic kidney or liver disease, and local factors like infection or previous radiation, also impair mechanobiological healing capacity. Notably, inappropriate immobilization or premature mechanical stress can compromise repair processes.

Clinical Features

Clinically, impaired healing manifests as delayed wound closure, persistent pain, edema, erythema, abnormal scarring (hypertrophic or atrophic), tissue necrosis, and in severe cases, wound dehiscence or fistula formation. In musculoskeletal surgery, impaired mechanobiological healing may present as non-union, malunion, or loss of function. Early recognition of these features is essential for timely intervention and prevention of chronic complications.

Diagnosis

Diagnosis relies on a combination of clinical assessment and adjunctive investigations. Serial wound evaluations assess healing progression, while imaging modalities such as ultrasound, MRI, or CT help detect deep tissue involvement, hematoma, or infection. Biomarkers reflecting inflammation, ECM turnover, or fibroblast activity (e.g., MMPs, TGF-β) may offer additional insights. Novel approaches, including biomechanical monitoring and tissue oxygenation mapping, are emerging as valuable diagnostic adjuncts in research and clinical practice.

Treatment & Management

Management strategies aim to optimize the local wound environment, enhance mechanical stability, and address patient-specific risk factors. Standard measures include meticulous surgical technique, tension-free closures, infection prevention, glycemic control, nutritional support, and cessation of smoking. Advanced wound care modalities such as negative pressure wound therapy, biologic dressings, and growth factor delivery may be employed for complex or non-healing wounds. Mechanical loading protocols, tailored to tissue and injury type, are increasingly recognized for their role in stimulating regenerative pathways and restoring function.

Recent Advances / Emerging Therapies

Recent research has illuminated the molecular underpinnings of mechanotransduction in tissue repair, driving the development of novel therapeutics. Pharmacologic agents targeting fibrosis (e.g., anti-TGF-β therapies), stem cell-based approaches, and bioengineered scaffolds designed to mimic physiological mechanical environments are under investigation. Biophysical interventions, such as low-intensity pulsed ultrasound and mechanomodulatory devices, show promise in enhancing repair outcomes. Personalized medicine approaches, leveraging patient-specific risk profiles and genetic markers, are poised to further refine management algorithms.

Guideline Recommendations

Current guidelines emphasize a multidisciplinary approach, integrating surgical best practices with perioperative risk modification and evidence-based wound care protocols. The Enhanced Recovery After Surgery (ERAS) protocols advocate for early mobilization and optimal nutrition, while specialty-specific guidelines underscore the importance of mechanical stability in orthopedic and reconstructive procedures. Ongoing updates reflect the growing body of evidence supporting mechanobiological principles in routine clinical decision-making.

Conclusion

Impaired mechanobiological healing following surgical tissue injury is a multifactorial process with substantial clinical implications. Advances in mechanistic understanding and therapeutic innovation offer hope for improved outcomes. Early identification of at-risk patients, adherence to guideline-based management, and the integration of emerging therapies are essential for optimizing tissue repair and minimizing postoperative complications. Further research and translation of mechanobiological insights will continue to shape the future of surgical care and tissue engineering.